Improving diabetes care using data from sensors and the environment
Leveraging the Exposome and Patient Sensor Data to Enhance Personalized Diabetes Care Across Diverse Communities
This study is testing if using data from health records, wearable devices, and environmental sensors can help improve diabetes care for people with type 2 diabetes living in vulnerable neighborhoods.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University of Illinois at Chicago Academic / other |
| Locations | 2 sites (Chicago, Illinois and 1 other locations) |
| Trial ID | NCT06989008 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance diabetes management for individuals with type 2 diabetes by integrating data from electronic health records, wearable devices, and environmental sensors. Participants will be monitored using continuous glucose monitoring (CGM) devices and physical activity trackers to gather comprehensive health data over a specified period. The study focuses on individuals living in vulnerable neighborhoods, ensuring that the findings are relevant to those who may benefit the most from personalized care. Data collection will involve both in-clinic visits and remote monitoring, allowing for a thorough analysis of how various factors influence diabetes management.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 18-65 with a diagnosis of type 2 diabetes residing in specific high social vulnerability zip codes.
Not a fit: Patients who do not speak or understand English or those unable to follow the research protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more personalized and effective diabetes care strategies for patients.
How similar studies have performed: Other studies have shown promise in using similar data integration approaches for chronic disease management, suggesting potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria * People with diabetes in the 18-65 years of age range * Diagnosed with type 2 diabetes * Resides in the specified high social vulnerability zip codes - 60619, 60620, 60621, 60636, 60644, 60624, 60609, 60612, 60617, 60623, 60628, 60629, 60639, 60645, 60649, 60651, 60652, 60653 * Speak and understand the English language * Willing to wear various devices (CGM and sports wristband) * Own a smartphone Exclusion Criteria * Subjects will be excluded from the study for the following reasons: * Any concern of not understanding informed consent * Unable to understand or unwilling to follow research protocol
Where this trial is running
Chicago, Illinois and 1 other locations
- University of Illinois - Chicago — Chicago, Illinois, United States (Recruiting)
- University of Illinois College of Nursing — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Andy Boyd, MD — University of Illinois at Chicago
- Study coordinator: Laurie Quinn, PhD
- Email: lquinn1@uic.edu
- Phone: 312 771 6497
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.